We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
As with all products, the MHRA will keep its safety under close review.
Chief Medical Officer for England, Professor Chris Whitty's annual reports and lectures on medicine and public health.
You may need to tell DVLA if you've had heart failure - download the form to let them know
Projects granted during 2014 that have a primary purpose of basic research into the cardiovascular, blood and lymphatic system.
Information on the reporting, investigation and management of Neonatal Enteroviral Myocarditis (NEM).
Find out about the long-term effects some people can have after having COVID-19.
Semaglutide is the first weight loss drug approved in the UK as a preventative treatment for those with established cardiovascular disease
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab and requires JavaScript).